Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 63.40%
March 31, 2026 59.79%
December 31, 2025 60.93%
September 30, 2025 58.26%
June 30, 2025 61.47%
March 31, 2025 60.50%
December 31, 2024 60.55%
September 30, 2024 60.61%
June 30, 2024 62.42%
March 31, 2024 59.43%
December 31, 2023 57.09%
September 30, 2023 58.92%
June 30, 2023 52.99%
March 31, 2023 53.21%
December 31, 2022 52.97%
September 30, 2022 53.58%
June 30, 2022 49.19%
March 31, 2022 56.26%
December 31, 2021 57.29%
September 30, 2021 55.95%
June 30, 2021 55.93%
March 31, 2021 57.38%
December 31, 2020 53.65%
September 30, 2020 62.91%
June 30, 2020 62.46%
Date Value
March 31, 2020 58.47%
December 31, 2019 62.03%
September 30, 2019 64.98%
June 30, 2019 63.37%
March 31, 2019 59.59%
December 31, 2018 61.65%
September 30, 2018 61.87%
June 30, 2018 59.16%
March 31, 2018 59.29%
December 31, 2017 58.48%
September 30, 2017 59.78%
August 31, 2016 59.75%
May 31, 2016 62.43%
February 29, 2016 57.52%
November 30, 2015 64.86%
August 31, 2015 61.16%
May 31, 2015 55.24%
February 28, 2015 54.05%
November 30, 2014 56.81%
August 31, 2014 62.50%
May 31, 2014 55.62%
February 28, 2014 58.96%
November 30, 2013 58.13%
August 31, 2013 56.90%
May 31, 2013 59.37%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Globus Medical, Inc. 65.92%
Abbott Laboratories 50.36%
AngioDynamics, Inc. 56.00%
Alphatec Holdings, Inc. 62.30%
AtriCure, Inc. 76.80%

Gross Profit Margin (Quarterly) Related Metrics